Motesanib
≥98%
- Product Code: 63003
CAS:
453562-69-1
| Molecular Weight: | 373.46 g./mol | Molecular Formula: | C₂₂H₂₃N₅O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD10567689 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Motesanib is primarily investigated for its potential in treating various types of cancer, particularly thyroid cancer, non-small cell lung cancer, and breast cancer. It works by inhibiting specific receptors involved in tumor growth and blood vessel formation, which can help slow down or stop the progression of cancer. Additionally, it is studied for its role in combination therapies, where it may enhance the effectiveness of other anticancer drugs. Researchers are also exploring its use in managing other conditions where abnormal blood vessel growth plays a significant role, such as certain eye diseases. Clinical trials continue to evaluate its safety, efficacy, and optimal dosing in different patient populations.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Off-white to Pale yellow to Khaki Solid,Powder or Crystals |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿2,880.00 |
+
-
|
Motesanib
Motesanib is primarily investigated for its potential in treating various types of cancer, particularly thyroid cancer, non-small cell lung cancer, and breast cancer. It works by inhibiting specific receptors involved in tumor growth and blood vessel formation, which can help slow down or stop the progression of cancer. Additionally, it is studied for its role in combination therapies, where it may enhance the effectiveness of other anticancer drugs. Researchers are also exploring its use in managing other conditions where abnormal blood vessel growth plays a significant role, such as certain eye diseases. Clinical trials continue to evaluate its safety, efficacy, and optimal dosing in different patient populations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :